Palomino Laboratories (PALX) Equity Average (2023 - 2025)

Palomino Laboratories has disclosed Equity Average across 3 years of filings, most recently posting $7.7 million for Q4 2025.

• Equity Average for Q4 2025 came in at $7.7 million, up 57931.19% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.7 million (up 57931.19% YoY), and the FY2025 annual result was $4.0 million, up 22167.58% from the prior year.
• Equity Average came in at $7.7 million for Q4 2025 at Palomino Laboratories, up from $3.4 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $7.7 million in Q4 2025 to a low of -$719444.5 in Q2 2025.
• The 3-year median for Equity Average is -$21501.8 (2023), against an average of $809538.0.
• Peak annual rise in Equity Average reached 66430.29% in 2025, while the deepest fall reached 32871.79% in 2025.
• Palomino Laboratories' Equity Average stood at -$48486.5 in 2023, then surged by 72.52% to -$13324.5 in 2024, then jumped by 57931.19% to $7.7 million in 2025.
• The last three Equity Average figures came in at $7.7 million (Q4 2025), $3.4 million (Q3 2025), and -$719444.5 (Q2 2025), per Business Quant data.